Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 13, Issue 9, Pages 985-995
Publisher
Informa UK Limited
Online
2017-08-04
DOI
10.1080/17425255.2017.1360280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis
- (2017) Niels Vande Casteele et al. PHARMACEUTICAL RESEARCH
- Immunogenicity of Anti-TNF-α Biotherapies: I. Individualized Medicine Based on Immunopharmacological Evidence
- (2015) Klaus Bendtzen Frontiers in Immunology
- Immunogenicity of Anti-TNF-α Biotherapies: II. Clinical Relevance of Methods Used for Anti-Drug Antibody Detection
- (2015) Klaus Bendtzen Frontiers in Immunology
- Evaluation of Pre-existing Antibody Presence as a Risk Factor for Posttreatment Anti-drug Antibody Induction: Analysis of Human Clinical Study Data for Multiple Biotherapeutics
- (2013) Li Xue et al. AAPS Journal
- A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies
- (2013) Sandra Garcês et al. ANNALS OF THE RHEUMATIC DISEASES
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012: Table 1
- (2013) Daniel E Furst et al. ANNALS OF THE RHEUMATIC DISEASES
- Biological Therapies for Rheumatoid Arthritis: Progress to Date
- (2013) Gaurav Malviya et al. BIODRUGS
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
- (2013) Casper Steenholdt et al. GUT
- Current immunotherapy in rheumatoid arthritis
- (2013) Florian MP Meier et al. Immunotherapy
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohnʼs Disease
- (2013) Casper Steenholdt et al. THERAPEUTIC DRUG MONITORING
- Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions
- (2013) Jose Ramon Maneiro et al. JAMA Internal Medicine
- Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
- (2012) Fabien B Vincent et al. ANNALS OF THE RHEUMATIC DISEASES
- The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis
- (2012) Sandra Garcês et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity
- (2012) Charlotte L. Krieckaert et al. ARTHRITIS AND RHEUMATISM
- Immunogenicity and autoimmunity during anti-TNF therapy
- (2012) F. Atzeni et al. AUTOIMMUNITY REVIEWS
- Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
- (2012) Aatke van der Maas et al. BMC MUSCULOSKELETAL DISORDERS
- Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine
- (2012) Klaus Bendtzen Immunotherapy
- Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment
- (2012) P. Emery RHEUMATOLOGY
- Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide
- (2012) Licia Maria Henrique da Mota et al. Revista Brasileira De Reumatologia
- Is there a need for immunopharmacologic guidance of anti-tumor necrosis factor therapies?
- (2011) Klaus Bendtzen ARTHRITIS AND RHEUMATISM
- Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases
- (2011) Andrea T. Borchers et al. JOURNAL OF AUTOIMMUNITY
- Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists
- (2011) Christophe Lallemand et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Differential effect of drug interference in immunogenicity assays
- (2011) Margreet H. Hart et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept
- (2010) A. Jamnitski et al. ANNALS OF THE RHEUMATIC DISEASES
- Dealing with immunogenicity of biologicals: assessment and clinical relevance
- (2010) Gerrit J Wolbink et al. CURRENT OPINION IN RHEUMATOLOGY
- Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
- (2010) Matthieu Allez et al. Journal of Crohns & Colitis
- A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients
- (2010) Pauline A. van Schouwenburg et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics
- (2010) Suzanna Tatarewicz et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The Complex Clinical Picture of Side Effects to Biologicals
- (2010) Oliver V. Hausmann et al. MEDICAL CLINICS OF NORTH AMERICA
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases
- (2009) Nádia Emi Aikawa et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies
- (2009) Klaus Bendtzen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
- (2008) E C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of anti-tumor necrosis factor antibodies—toward improved methods of anti-antibody measurement
- (2008) Lucien Aarden et al. CURRENT OPINION IN IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started